Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...

The cuts impact more than $2.4 billion in grant money, including $1.3 billion in grant money already spent on projects ...

Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...

Implanted BCIs are electrodes put in paralyzed people’s brains so they can use imagined movements to send commands from their ...

Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces full year 2024 ...

PM Narendra Modi, industrialist Ratan Tata, biotech pioneer Raj Bhan, and mathematician Srinivasa Ramanujan. Gates recalls ...

Budget cuts, delays to grant reviews, and layoffs of federal workers at agencies like the NIH and the National Science Foundation have affected nearly every research organization in the US. If ...

According to the report, titled "India Bioeconomy Report 2025", the bioeconomy sector witnessed a 16-fold expansion in the ...

Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...

Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...